Pariet
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background In 2003, British Columbia’s PharmaCare programme implemented a drug reimbursement policy called Therapeutic…
Total expenditure under the Community Drugs Schemes in Ireland on the proton pump inhibitors (PPI's) used for the management of…
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex…
Three groups of patients were studied with the purpose of assessing the efficiency of the application of Pariet in the complex…
The results on estimation of efficiency and safety of monotherapy by Rabeprasol in dose 20 mg per day in treatment of the…
Proton pomp inhibitors (PPI) have revolutionized the treatment of gastro-oesophageal reflux disease and gastro-duodenal ulcers…
In the article the results of the eradication therapy by Pariet in the patients suffering from the duodenal ulcer disease…
The article provides the data on 20 patients with erosive reflux esophagitis, who were treated with Pariet (rabeprazole). It was…
The criteria of choice of proton pump inhibitor at acid-dependent diseases such as gastroesophageal reflux, peptic ulcer…